Annual Operating Expenses
$24.97 M
+$4.77 M+23.59%
December 1, 2023
Summary
- As of February 7, 2025, ACTU annual total operating expenses is $24.97 million, with the most recent change of +$4.77 million (+23.59%) on December 1, 2023.
- During the last 3 years, ACTU annual operating expenses has risen by +$4.77 million (+23.59%).
- ACTU annual operating expenses is now at all-time high.
Performance
ACTU Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$5.39 M
-$42.50 K-0.78%
September 1, 2024
Summary
- As of February 7, 2025, ACTU quarterly total operating expenses is $5.39 million, with the most recent change of -$42.50 thousand (-0.78%) on September 1, 2024.
- Over the past year, ACTU quarterly operating expenses has dropped by -$42.50 thousand (-0.78%).
- ACTU quarterly operating expenses is now -30.62% below its all-time high of $7.77 million, reached on March 1, 2024.
Performance
ACTU Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
ACTU Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +23.6% | -0.8% |
| 3 y3 years | +23.6% | -0.8% |
| 5 y5 years | +23.6% | -0.8% |
ACTU Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +23.6% | -30.6% | +1.8% |
| 5 y | 5-year | at high | +23.6% | -30.6% | +1.8% |
| alltime | all time | at high | +23.6% | -30.6% | +1.8% |
Actuate Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $5.39 M(-0.8%) |
| Jun 2024 | - | $5.44 M(-30.1%) |
| Mar 2024 | - | $7.77 M(+2.1%) |
| Dec 2023 | $24.97 M | $7.62 M(+17.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $6.48 M(+16.0%) |
| Jun 2023 | - | $5.58 M(+5.4%) |
| Mar 2023 | - | $5.30 M |
| Dec 2022 | $20.21 M | - |
FAQ
- What is Actuate Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Actuate Therapeutics?
- What is Actuate Therapeutics annual operating expenses year-on-year change?
- What is Actuate Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Actuate Therapeutics?
- What is Actuate Therapeutics quarterly operating expenses year-on-year change?
What is Actuate Therapeutics annual total operating expenses?
The current annual operating expenses of ACTU is $24.97 M
What is the all time high annual operating expenses for Actuate Therapeutics?
Actuate Therapeutics all-time high annual total operating expenses is $24.97 M
What is Actuate Therapeutics annual operating expenses year-on-year change?
Over the past year, ACTU annual total operating expenses has changed by +$4.77 M (+23.59%)
What is Actuate Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of ACTU is $5.39 M
What is the all time high quarterly operating expenses for Actuate Therapeutics?
Actuate Therapeutics all-time high quarterly total operating expenses is $7.77 M
What is Actuate Therapeutics quarterly operating expenses year-on-year change?
Over the past year, ACTU quarterly total operating expenses has changed by -$42.50 K (-0.78%)